Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin

European Journal of Pharmacology

Volumn 574, Issue 2-3, 2007, Pages 179-184

  Gao, Qin ^a   Yang, Bo ^a   Ye, Zhi guo ^a   Wang, Jue ^a   Bruce, Iain C ^a   Xia, Qiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Calcium activated potassium channel; Heart; Ischemia and reperfusion; Puerarin

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CHELERYTHRINE; FORMAZAN; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PAXILLINE; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PUERARIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE WALL; IN VITRO STUDY; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ALKALOIDS; ANIMALS; ANTIOXIDANTS; BENZOPHENANTHRIDINES; CARDIOTONIC AGENTS; INDOLES; ISOFLAVONES; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 35348870371     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.018     Document Type: Article

References (33)

1. Cao C.M., Xia Q., Gao Q., Chen M., and Wong T.M. Calcium activated potassium channel triggers cardioprotection of ischemic preconditioning. J. Pharmacol. Exp. Ther. 312 (2004) 644-650
2. Cao C.M., Chen M., and Wong T.M. The K(Ca) channel as a trigger for the cardioprotection induced by kappa-opioid receptor stimulation - its relationship with protein kinase C. Br. J. Pharmacol. 145 (2005) 984-991
3. Chen J., Xu J., and Li J. Effect of puerarin on fibrinolytic activity and lipid peroxide in patients with coronary heart disease. Zhongguo Zhong-Xiyi Jiehe Zazhi 19 (1999) 649-650
4. Chen J., and Mehta J.L. Role of oxidative stress in coronary heart disease. Indian Heart J. 56 (2004) 163-173
5. Cheung R.T., Tipoe G.L., Tam S., Ma E.S., Zou L.Y., and Chan P.S. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J. Pineal Res. 41 (2006) 337-343
6. Dong K., Tao Q.M., Shan Q.X., Jin H.F., Pan G.B., Chen J.Z., Zhu J.H., and Xia Q. Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta. Conf. Proc. -IEEE Eng. Med. Biol. Soc. 5 (2004) 3757-3760
7. Duan S., Li Y.F., and Luo X.L. Effect of puerarin on heart function and serum oxidized-LDL in the patients with chronic cardiac failure. Hunan Yike Daxue Xuebao 25 (2000) 176-178
8. Fan L.L., Sun L.H., Li J., Yue X.H., Yu H.X., and Wang S.Y. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function. Chin. Med. J. (Engl.) 105 (1992) 11-17
9. + channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha. Cytokine 32 (2005) 199-205
10. Gao Q., Pan H.Y., Qiu S., Lu Y., Bruce I.C., Luo J.H., and Xia Q. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart. Life Sci. 79 (2006) 217-224
11. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc. Res. 55 (2002) 534-543
12. Hausenloy D.J., Wynne A., Duchen M., and Yellon D.M. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109 (2004) 1714-1717
13. Hiebert L., and Ping T. Protective effect of dextran sulfate and heparin on adult rat cardiomyocytes damaged by free radicals. J. Mol. Cell. Cardiol. 29 (1997) 229-235
14. Jiang R.W., Lau K.M., Lam H.M., Yam W.S., Leung L.K., Choi K.L., Waye M.M., Mak T.C., Woo K.S., and Fung K.P. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J. Ethnopharmacol. 96 (2005) 133-138
15. Logue S.E., Gustafsson A.B., Samali A., and Gottlieb R.A. Ischemia/reperfusion injury at the intersection with cell death. J. Mol. Cell. Cardiol. 38 (2005) 21-33
16. Miki T., Cohen M.V., and Downey J.M. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol. Cell. Biochem. 186 (1998) 3-12
17. Miyata Y., Sato T., Yano M., and Ito A. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Mol. Cancer Ther. 3 (2004) 839-847
18. O'Rourke B., Cortassa S., and Aon M.A. Mitochondrial ion channels: gatekeepers of life and death. Physiologist (Bethesda Md.) 20 (2005) 303-315
19. Peart J.N., and Gross G.J. Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am. J. Physiol, Heart Circ. Physiol. 291 (2006) H1746-H1753
20. + channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A. Circulation 111 (2005) 198-203
21. Solaini G., and Harris D.A. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem. J. 390 (2005) 377-394
22. Swift L.M., and Sarvazyan N. Localization of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress. Am. J. Physiol, Heart Circ. Physiol. 278 (2000) H982-H990
23. Ursini F., Maiorino M., Morazzoni P., Roveri A., and Pifferi G. A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activation. Free Radic. Biol. Med. 16 (1994) 547-553
24. Vander Heide R.S., Rim D., Hohl C.M., and Ganote C.E. An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J. Mol. Cell. Cardiol. 22 (1990) 165-181
25. Wang Q., Wu T., Chen X., Ni J., Duan X., Zheng J., Qiao J., Zhou L., and Wei J. Puerarin injection for unstable angina pectoris. Cochrane Database Syst. Rev. 3 (2006) CD004196
26. Wu P., Zeng F., and Ma H.X. Study on effect of puerarin on nitric oxide system in rats' tissue and its mechanism. Zhongguo Zhong-Xiyi Jiehe Zazhi 21 (2001) 196-198
27. Xie R.Q., Du J., and Hao Y.M. Myocardial protection and mechanism of puerarin injection on patients of coronary heart disease with ischemia/reperfusion. Zhongguo Zhong-Xiyi Jiehe Zazhi 23 (2003) 895-897
28. Xiong F.L., Sun X.H., Gan L., Yang X.L., and Xu H.B. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur. J. Pharmacol. 529 (2006) 1-7
29. + channels in the cardiac inner mitochondrial membrane. Science 298 (2002) 1029-1033
30. + current in mice hippocampal CA1 neurons. Acta Pharm. Sin. 22 (2001) 253-256
31. Zhang Y., Irwin M.G., Wong T.M., Chen M., and Cao C.M. Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. Anesthesiology 102 (2005) 371-378
32. Zhao Z.Q. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr. Opin. Pharmacol. 4 (2004) 159-165
33. Zhou X., Zhai X., and Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 93 (1996) 1177-1184